Neauvia’s Achievement at the AMWC 2024 Awards in Monaco

Neauvia is honoured to announce its distinguished success at the AMWC 2024 Awards held in Monaco. The company proudly received the "Best Injectable Dermal Filler" award for its groundbreaking product, STIMULATE, the only PEG-HA + CaHA filler.

The AMWC Awards, internationally renowned for their commitment to acknowledging innovation and excellence in the global medical aesthetic market, spotlighted Neauvia as a leader in the category of Injectable Dermal Fillers.

Winners were announced at AMWC Congress on March 27th, 2024. This prestigious international recognition, conferred by a panel of esteemed jurors and open for voting by all professionals in the Aesthetic Medicine Community, reaffirms Neauvia's dedication to rethinking medical aesthetics.

"We are proud to receive this renowned award and acknowledgement. These achievements highlight Neauvia's Red Team dedication and our commitment to innovation in the Medical Aesthetics landscape."
- Gabriele Drigo, founder and CEO of Neauvia.

STIMULATE stands out as the only PEG-HA + CaHA Filler in the market.

It is a groundbreaking injectable made of Hyaluronic Acid (HA) cross-linked with PEG, enriched with Glycine, L-Proline and Calcium Hydroxyapatite (CaHA).

Its advanced formulation has been demonstrated to effectively address skin and subcutaneous tissue concerns, in particular, the correction of disorders and the correction of mid-face volume deficit. ^[Ref1]

The collected data highlight an efficient mechanical effect of the PEGylated polymeric acid matrix enriched with CaHA, aligning with other evidence in vitro and in vivo. ^[Ref1]

“Through STIMULATE, Neauvia showcases its continuous dedication to pioneering R&D and medical excellence. Trusted by thousands of doctors worldwide, STIMULATE epitomizes Neauvia's commitment, delivering patient satisfaction with its safety and efficacy.”

- Professor Nicola Zerbinati, Dermatologist and Neauvia Chief Scientific Officer

Find out more:

UK: neauvia.uk/digital-brochures

Neauvia Education Channel www.neauviachannel.com

Global: www.neauvia.com

<sup>References :
1. Zerbinati N, D’Este E, De Silvestri A, Zullino M, Rabbiosi G, Guida S, Kubik P, Stabile G, Mocchi R, Barlusconi C et al. Efficacy of</sup>

^{Pegylated Hyaluronic Acid filler enriched with Calcium Hydroxyapatite: a 24-week post-market, observational, prospective, open-
label, single-center study. J. Funct. Biomater. 2023, 14, 345. https://doi.org/10.3390/jfb14070345.}